← Leaderboards
Travis Scott Young
Harvard Medical School
$1,970,003
Attributed
$1,970,003
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.7K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,970,003 · 2
By mechanism
R01$1,887,890 · 1
F32$82,113 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Suzanne L. Walker$40,048,648
- Matthew F Traxler$3,068,267
- Danica Galonic Fujimori$12,238,379
- Thomas G Bernhardt$19,734,051
- Marc W Kirschner$55,400,682
Others in their field
Top investigators on “Clinic”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,108,147,906
- Leonard Freedman · Leidos Biomedical Research, Inc.$978,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$798,941,641
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$639,436,363
- Barton F Haynes · Duke University$546,907,423
Research focus
ClinicCostCellsChimeric Antigen ReceptorAdverse EventClinical TrialsCancer TherapyCd19 GeneCell TherapyAntibodiesAntibody EngineeringAntigensAntigen TargetingAffectAcute Lymphocytic LeukemiaBaseB-Cell LeukemiaB-Cell NeoplasmBench To BedsideB-LymphocytesB Lymphoid MalignancyCancer CellCancer Clinical TrialCytokine
Grant awards (7)
CAR-T cell control through orthogonal antibody-based switches$326,972
R01 · FY2020 · CA · contact PI
CAR-T cell control through orthogonal antibody-based switches$317,163
R01 · FY2019 · CA · contact PI
CAR-T cell control through orthogonal antibody-based switches$412,234
R01 · FY2018 · CA · contact PI
CAR-T cell control through orthogonal antibody-based switches$411,782
R01 · FY2017 · CA · contact PI
CAR-T cell control through orthogonal antibody-based switches$419,739
R01 · FY2016 · CA · contact PI
Thiazolyl peptide analogs that provide insight into antibiotic targeting$33,715
F32 · FY2012 · GM · contact PI
Thiazolyl peptide analogs that provide insight into antibiotic targeting$48,398
F32 · FY2011 · GM · contact PI